BA
LKFT

BlackRock Advisors’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

BlackRock Advisors’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-53,000
Closed -$2.73M – 3776
2015
Q2 		$2.73M Buy
+53,000
New +$2.81M ﹤0.01% 1158

Other funds holding LKFT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

BlackRock Advisors's LKFT Position: Q3 2015 in Review

BlackRock Advisors sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q3 2015, closing a stake of 53,000 shares — an estimated $2.73M sold.

BlackRock Advisors first reported a position in LKFT in Q2 2015 and held it in 1 quarter. The position peaked at $2.73M in Q2 2015. 38 funds tracked by Wall St. Rank hold LKFT as of Q3 2015.

  • BlackRock Advisors reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q3 2015 after selling out during the quarter.
  • BlackRock Advisors sold 53,000 Lakefront Biotherapeutics American Depositary Shares shares in Q3 2015, an estimated $2.73M.
  • BlackRock Advisors first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q2 2015 and held it in 1 quarter.
  • BlackRock Advisors's Lakefront Biotherapeutics American Depositary Shares position peaked at $2.73M in Q2 2015.
  • 38 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q3 2015.

Based on BlackRock Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.